Integra Lifesciences Holdings Corp (IART) insider trading
Every open-market stock purchase and sale by Integra Lifesciences Holdings Corp executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $102K over the last 12 months (1 buy).
- Last insider buy: Jeffrey A Graves (Director), $102K, 12 months ago.
Last 12 months: insiders bought $102K (1 buy) and sold $0 (0 sales). Last close $11.84 on Oct 21, 2026.
Recent IART insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | Chantal Veillon-Berteloot (VP) | Sold (not open market) | $24.2K |
| Jul 3, 2026 | Lea Daniels Knight (CFO) | Sold (not open market) | $94.3K |
| Jul 1, 2026 | Jeffrey Mosebrook (VP) | Sold (not open market) | $16.8K |
| Jul 1, 2026 | Harvinder Singh (President) | Bought (not open market) | — |
| Jul 1, 2026 | Robert T. Davis Jr. (President) | Bought (not open market) | — |
| Jun 1, 2026 | Michael J. McBreen (C-suite exec) | Bought (not open market) | — |
| Jun 1, 2026 | Michael J. McBreen (C-suite exec) | Bought (not open market) | — |
| Jun 1, 2026 | Stuart Essig (CEO) | Bought (not open market) | — |
| Jun 1, 2026 | Stuart Essig (CEO) | Bought (not open market) | — |
| May 9, 2026 | Keith Bradley (Director) | Sold (not open market) | $12.3K |
| May 7, 2026 | Keith Bradley (Director) | Bought (not open market) | — |
| May 7, 2026 | Shaundra Clay (Director) | Bought (not open market) | — |
| May 7, 2026 | Jeffrey A Graves (Director) | Bought (not open market) | — |
| May 7, 2026 | Barbara B Hill (Director) | Bought (not open market) | — |
| May 7, 2026 | Christian S Schade (Director) | Bought (not open market) | — |
| May 7, 2026 | Barbara B Hill (Director) | Bought (not open market) | — |
| May 7, 2026 | Renee Wonlai Lo (Director) | Bought (not open market) | — |
| Mar 11, 2026 | Robert T. Davis Jr. (President) | Sold (not open market) | $81.6K |
| Mar 11, 2026 | Lea Daniels Knight (CFO) | Sold (not open market) | $77.7K |
| Mar 11, 2026 | Michael J. McBreen (President) | Sold (not open market) | $69.6K |
| Mar 11, 2026 | Chantal Veillon-Berteloot (VP) | Sold (not open market) | $52.1K |
| Mar 11, 2026 | Harvinder Singh (President) | Sold (not open market) | $49.9K |
| Mar 11, 2026 | Harvinder Singh (President) | Sold (not open market) | $8.3K |
| Mar 11, 2026 | Jeffrey Mosebrook (VP) | Sold (not open market) | $7.7K |
| Mar 11, 2026 | Harvinder Singh (President) | Bought (not open market) | — |
Who's trading IART
- Chantal Veillon-Berteloot, VP: other filings, last Sep 1, 2026
- Lea Daniels Knight, CFO: other filings, last Jul 3, 2026
- Jeffrey Mosebrook, VP: other filings, last Jul 1, 2026
- Robert T. Davis Jr., President: other filings, last Jul 1, 2026
- Harvinder Singh, President: other filings, last Jul 1, 2026
- Michael J. McBreen, President: other filings, last Jun 1, 2026
- Stuart Essig, Chair: other filings, last Jun 1, 2026
- Keith Bradley, Director: other filings, last May 9, 2026
- Shaundra Clay, Director: other filings, last May 7, 2026
- Jeffrey A Graves, Director: bought $102K (1 buy), last May 7, 2026
- Barbara B Hill, Director: other filings, last May 7, 2026
- Renee Wonlai Lo, Director: other filings, last May 7, 2026
- Christian S Schade, Director: other filings, last May 7, 2026
- Mojdeh Poul, CEO: other filings, last Mar 11, 2026
- Michael Damon Hutchinson, C-suite exec: other filings, last Mar 11, 2026
Get free alerts when an insider at Integra Lifesciences Holdings Corp files a new trade →